Oral thin films are a modern oral drug delivery method developed based on transdermal patch technology. Like tablets, the physical structure and low moisture content of the film make it an inhospitable environment for microbial growth, thus minimizing the need for preservatives and providing greater stability and shelf life. In the manufacture of oral thin films, solvent casting, and hot-melt extrusion are dominant. Hot-melt extrusion is a repeatable, continuous, which is often used to produce a novel solvent-free oral thin film. CD Formulation has a professional solvent-free mouth soluble film technology development platform, providing the whole process service from formula design, quality control to commercial production.
In general, the preparation of oral thin film requires three main components, film-forming polymer, APIs, and plasticizer. To ensure the flexibility of the solvent-free oral thin film and easier to act on the application site, we will add other ingredients such as biological adhesives in the development process of the solvent-free oral thin film to ensure that the film can adhere to the action site within a certain period, allowing the drug to be absorbed or work.
The production of solvent-free oral thin film is to heat the APIs and excipients after mixing, and then extrude the hot soluble substance through the mold hole to form a rod, and then press it into a film with a cooling roller. In this process, solvent-free heat treatment is used to realize the mixing and film formation of each component. Due to the high temperature involved in the production process, the thermal degradation of the drug or excipient used in the preparation may occur, so we perform a thermogravimetric analysis to evaluate the thermal behavior of the formula and select the appropriate processing temperature range.
Fig.1 The thermal degradation curves for raw materials and physical mixtures. (Jiaxiang Zhang., et al., 2021)
Our experienced technicians carry out comprehensive quality control, including appearance, film thickness, content and content uniformity, texture analysis, film disintegration, dissolution in simulated saliva, etc.
We have very rich experience in pilot transfer of solvent-free oral thin film, and we also have strong manufacturing capabilities.
Technologies & Platforms | Specifics Contents |
3D Printed Technology Platform | 3D Printed Technology has emerged as an attractive technology to fabricate a wide array of pharmaceutical dosage forms, builds objects layer by layer from a computer-aided digital design. |
Thermogravimetric (TGA) Analysis Platform | Since a solvent-free thermal process is utilized in the current investigation to achieve molecular level mixing and film forming, a thermal degradation of the drug or excipients used in the formulations might happen due to the high processing temperature of the casting, extrusion, and printing. Thus, TGA is conducted to assess the thermal behavior of the formulations and select a suitable processing temperature range before performing actual HME and 3D printing. |
Films Morphology Analysis Platform | The films are cut into 10 × 10 mm pieces, and a digital caliper is used to determine the thickness and dimensions of the films. The weight of extruded and printed filaments is measured using an analytical balance. Furthermore, an optical microscope is used to image the samples. |
Technology: Development and Evaluation of Amorphous Oral Thin Films Using Solvent-Free Processes
Journal: Pharmaceutics
IF: 5.4
Published: 2021
Results: In this study, the main objective is to develop oral thin film (OTF) formulations using novel solvent-free approaches, including additive manufacturing (AM), hot-melt extrusion, and melt casting. This study suggested that HME combined with 3D printing can potentially improve the physical properties of formulations and produce OTFs with preferred qualities such as faster dissolution rate of drugs.
Fig.2 Development and Evaluation of Amorphous Oral Thin Films Using Solvent-Free. (Jiaxiang Zhang., et al., 2021)
CD Formulation is at the forefront of innovative drug delivery system development, providing customized solutions for the development of novel drug delivery systems. Our expertise lies in the use of advanced technology and processes to design safe, efficient and reliable novel solvent-free oral thin film. If you have a requirement about our novel solvent-free oral thin film development services, please contact us by phone or email, and our colleagues will reply to you within three working days.
References